AU Stock MarketDetailed Quotes

AGN Argenica Therapeutics Ltd

Watchlist

0.860
+0.010+1.18%

20min DelayMarket Closed Jul 18 15:57 AET

106.38MMarket Cap-15636P/E (Static)

Argenica Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Operating cash flow (direct method)

Cash income from operating activities

845.21%2.45M

-12.49%259.1K

296.08K

Revenue from customers

----

----

--145K

Income from government grants

--1.07M

----

----

Other cash income from operating activities

431.81%1.38M

71.50%259.1K

--151.08K

Cash paid

-60.37%-5.81M

-169.79%-3.62M

-1.34M

Payments to suppliers for goods and services

-60.37%-5.81M

-169.79%-3.62M

---1.34M

Direct interest paid

-27.74%-1.05K

-4,010.00%-822

---20

Direct interest received

2,335.98%61K

1,139.60%2.5K

--202

Direct tax refund paid

----

----

--47

Operating cash flow

1.83%-3.3M

-221.26%-3.36M

---1.05M

Investing cash flow

Cash flow from continuing investing activities

-50K

Net investment purchase and sale

---50K

----

----

Cash from discontinued investing activities

Investing cash flow

---50K

----

----

Financing cash flow

Cash flow from continuing financing activities

-27.42%3.73M

-34.61%5.13M

7.85M

Net common stock issuance

-27.42%3.73M

-34.61%5.13M

--7.85M

Cash from discontinued financing activities

Financing cash flow

-27.42%3.73M

-34.61%5.13M

--7.85M

Net cash flow

Beginning cash position

24.78%8.91M

1,989.04%7.14M

--341.98K

Current changes in cash

-78.83%374.7K

-73.98%1.77M

--6.8M

End cash Position

4.20%9.29M

24.78%8.91M

--7.14M

Free cash from

1.83%-3.3M

-221.26%-3.36M

---1.05M

Accounting Standards

US-GAAP

US-GAAP

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities	845.21%2.45M	-12.49%259.1K	296.08K
Revenue from customers	----	----	--145K
Income from government grants	--1.07M	----	----
Other cash income from operating activities	431.81%1.38M	71.50%259.1K	--151.08K
Cash paid	-60.37%-5.81M	-169.79%-3.62M	-1.34M
Payments to suppliers for goods and services	-60.37%-5.81M	-169.79%-3.62M	---1.34M
Direct interest paid	-27.74%-1.05K	-4,010.00%-822	---20
Direct interest received	2,335.98%61K	1,139.60%2.5K	--202
Direct tax refund paid	----	----	--47
Operating cash flow	1.83%-3.3M	-221.26%-3.36M	---1.05M
Investing cash flow
Cash flow from continuing investing activities	-50K
Net investment purchase and sale	---50K	----	----
Cash from discontinued investing activities
Investing cash flow	---50K	----	----
Financing cash flow
Cash flow from continuing financing activities	-27.42%3.73M	-34.61%5.13M	7.85M
Net common stock issuance	-27.42%3.73M	-34.61%5.13M	--7.85M
Cash from discontinued financing activities
Financing cash flow	-27.42%3.73M	-34.61%5.13M	--7.85M
Net cash flow
Beginning cash position	24.78%8.91M	1,989.04%7.14M	--341.98K
Current changes in cash	-78.83%374.7K	-73.98%1.77M	--6.8M
End cash Position	4.20%9.29M	24.78%8.91M	--7.14M
Free cash from	1.83%-3.3M	-221.26%-3.36M	---1.05M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall